Welcome to LookChem.com Sign In|Join Free
  • or
N-[3-(3-Dimethylaminoacryloyl)phenyl]-N-ethylacetamide-d5, also known as (E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-ethylacetamide-d5, is a labeled analogue of (E)-N-(3-(3-(Dimethylamino)acryloyl)phenyl)-N-ethylacetamide (D461435). It is primarily used as an intermediate in the production of labeled Zaleplon, a selective non-benzodiazepine GABAA receptor agonist.

1104483-92-2

Post Buying Request

1104483-92-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1104483-92-2 Usage

Uses

Used in Pharmaceutical Industry:
N-[3-(3-Dimethylaminoacryloyl)phenyl]-N-ethylacetamide-d5 is used as an impurity and intermediate for the production of labeled Zaleplon (Z145000). It plays a crucial role in the synthesis of impurities associated with Zaleplon, which is a GABAA receptor agonist with potential applications in the treatment of anxiety, insomnia, and other conditions related to the central nervous system.
Used in Research and Development:
As a labeled analogue, N-[3-(3-Dimethylaminoacryloyl)phenyl]-N-ethylacetamide-d5 is also utilized in research and development for the study of Zaleplon and its related compounds. This labeled compound can be employed in various analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, to investigate the structure, properties, and interactions of Zaleplon and its impurities.

Check Digit Verification of cas no

The CAS Registry Mumber 1104483-92-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,4,4,8 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1104483-92:
(9*1)+(8*1)+(7*0)+(6*4)+(5*4)+(4*8)+(3*3)+(2*9)+(1*2)=122
122 % 10 = 2
So 1104483-92-2 is a valid CAS Registry Number.

1104483-92-2Downstream Products

1104483-92-2Relevant academic research and scientific papers

Synthesis of deuterium-labeled zaleplon-d5 as an internal standard

Shaikh, Ajam C.,Chen, Chinpiao

, p. 72 - 76 (2008)

Zaleplon is licensed for the short-term treatment of insomnia. Excessive usage causes side effects; hence, the drug is controlled. Identifying zaleplon in a drug abuser requires an isotope-labeled internal standard. This work presents a synthesis of stable isotope-labeled internal standard for zaleplon, zaleplon-d5, by a five-step synthetic sequence. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1104483-92-2